• Title/Summary/Keyword: polymer microparticles

Search Result 49, Processing Time 0.032 seconds

Fabrication of Biodegradable Polyphosphazene Microparticles by Electrohydrodynamic Atomization (전기분무에 의한 생분해성 폴리포스파젠 마이크로입자의 제조)

  • Xue, Li-Wei;Cai, Qing;Ryu, Seung-Kon;Jin, Ri-Guang
    • Polymer(Korea)
    • /
    • v.35 no.5
    • /
    • pp.424-430
    • /
    • 2011
  • Biodegradable poly[(glycine ethyl ester)-(phenylalanine ethyl ester) phosphazene](PGPP) microparticles were fabricated by electrohydrodynamic atomization to apply drug release test. Atomization parameters such as applied voltage, polymer concentration, and molecular weight were investigated to inspect their effects on the size and morphology of microparticles. The average diameter of PGPP microparticles decreased as increasing applied voltage and solution flow rate. Dichloromethane/dioxane mixture shows better results for the preparation of microparticles than single solvent owing to the different PGPP solubility in solvent. Blending PGPP polymers with proper molecular weights not only favored the production of spherical PGPP microparticles via electrohydrodynamic atomization, but also provided a way to adjust drug (rifampicin) release behavior. Drug-loaded biodegradable polyphosphazene microspheres can be fabricated via electrohydrodynamic atomization, which has potential use in biomedical applications.

Production of Gemcitabine-Loaded Poly (L-lactic acid) Microparticles Using Supercritical Carbon Dioxide: Effect of Process Parameters (초임계 이산화탄소를 이용한 Gemcitabine 함유 PLLA 미립자 제조: 공정 변수의 영향)

  • Joo, Hyun-Jae;Jung, In-Il;Lim, Gio-Bin;Ryu, Jong-Hoon
    • KSBB Journal
    • /
    • v.26 no.1
    • /
    • pp.69-77
    • /
    • 2011
  • In this study, poly (L-lactic acid) (PLLA) microparticles containing gemcitabine hydrochloride were prepared by a supercritical fluid process, called aerosol solvent extraction system (ASES), utilizing supercritical carbon dioxide as antisolvent. The influence of process parameters such as temperature, pressure, $CO_2$ and solution flow rate, solution concentration, and feed ratio of drug to polymer on the morphology and characteristics of the microparticles was studied in detail. The gemcitabine-loaded microparticles exhibited a spherical shape with a smooth surface. The entrapment efficiency of gemcitabine increased with increasing temperature, solution concentration and $CO_2$ flow rate and with decreasing drug/polymer feed ratio. The maximum drug loading obtained from the ASES process was found to be about 11%. The ASES-processed PLLA microparticles containing gemcitabine showed a relatively high initial burst due to the presence of surface pores on the microparticles and the poor affinity between drug and polymer.

Preparation of Gemcitabine-Loaded Methoxy Poly(ethylene glycol)-b-Poly(L-lactide) Microparticles Using W/O/W Double Emulsion (W/O/W 다중유화법을 이용한 젬시타빈 함유 Methoxy Poly(ethylene glycol)-b-Poly(L-lactide) 미립자 제조)

  • Ryu, Jong-Hoon;Jung, In-Il;Lee, Ji-Eun;Lim, Gio-Bin
    • KSBB Journal
    • /
    • v.26 no.4
    • /
    • pp.333-340
    • /
    • 2011
  • In this study, gemcitabine-loaded methoxy poly(ethylene glycol)-b-poly(L-lactide) (MPEG-PLLA) microparticles with different PEG block lengths were prepared by a W/O/W double emulsion technique. The present study focuses on the investigation of the influence of various preparative parameters such as the ratio of internal water phase and oil phase, polymer concentration, solvent composition of organic phase and salt concentration of external water phase on the morphology and encapsulation efficiency of the microparticles. The microparticles fabricated at high volume ratios of internal water phase to oil phase and at high polymer concentrations showed a relatively high encapsulation efficiency and low porosity. When a dichloromethane/ethyl acetate mixture was used as solvent, both the encapsulation efficiency and drug loading of the microparticles decreased as the level of ethyl acetate increased. The addition of a salt (NaCl) to the external water phase significantly improved the encapsulation efficiency up to 40%, and the microparticles became more spherical with their size and porosity decreased.

Core-shell Poly(D,L-lactide-co-glycolide )/Poly(ethyl 2-cyanoacrylate) Microparticles with Doxorubicin to Reduce Initial Burst Release

  • Lee, Sang-Hyuk;Baek, Hyon-Ho;Kim, Jung-Hyun;Choi, Sung--Wook
    • Macromolecular Research
    • /
    • v.17 no.12
    • /
    • pp.1010-1014
    • /
    • 2009
  • Monodispersed microparticles with a poly(D,L-lactide-co-glycolide) (PLGA) core and a poly(ethyl 2-cyanoacrylate) (PE2CA) shell were prepared by Shirasu porous glass (SPG) membrane emulsification to reduce the initial burst release of doxorubicin (DOX). Solution mixtures with different weight ratios of PLGA polymer and E2CA monomer were permeated under pressure through an SPG membrane with $1.9\;{\mu}m$ pore size into a continuous water phase with sodium lauryl sulfate as a surfactant. Core-shell structured microparticles were formed by the mechanism of anionic interfacial polymerization of E2CA and precipitation of both polymers. The average diameter of the resulting microparticles with various PLGA:E2CA ratios ranged from 1.42 to $2.73\;{\mu}m$. The morphology and core-shell structure of the microparticles were observed by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The DOX release profiles revealed that the microparticles with an equivalent PLGA:E2CA weight ratio of 1:1 exhibited the optimal condition to reduce the initial burst of DOX. The initial release rate of DOX was dependent on the PLGA:E2CA ratio, and was minimized at a 1:1 ratio.

Fabrication of Porous Silk Fibroin Microparticles by Electrohydrodynamic Spraying (전기분사법에 의한 다공성 실크 피브로인 미세입자의 제조)

  • Kim, Moo Kon;Lee, Ki Hoon
    • Polymer(Korea)
    • /
    • v.38 no.1
    • /
    • pp.98-102
    • /
    • 2014
  • Nowadays, silk fibroin receives a lot of attention as novel natural biomaterials due to its excellent biocompatibility and biodegradability. Electrohydrodynamic spraying (EHDS) is one of the method for the preparation of micro or nanoparticles by applying high voltage to the polymer solution. In this research, we fabricated silk fibroin porous microparticles by electrohydrodynamic spraying. Poly(ethylene glycol) (PEG) was added to the fibroin solution to give pores to silk fibroin microparticles. By the addition of PEG, the microparticle size was decreased despite of the decrease in conductivity and the increase of viscosity of the spraying solution. It seems that the immiscibility of silk fibroin and PEG affected much more to the microparticle size than the conductivity and viscosity. Immersing the as-sprayed microparticles into the water removed the phase-separated PEG, and finally, porous silk fibroin microparticles were prepared. The porous silk fibroin microparticles are expected to be applied as drug carriers in drug delivery or cell carriers in tissue engineering.

Development of Drug-Loaded PLGA Microparticles with Different Release Patterns for Prolonged Drug Delivery

  • Choi, Yeon-Soon;Joo, Jae-Ryang;Hong, Areum;Park, Jong-Sang
    • Bulletin of the Korean Chemical Society
    • /
    • v.32 no.3
    • /
    • pp.867-872
    • /
    • 2011
  • For the prolonged delivery and sustained release rates of low molecular weight drugs, poly(lactic-co-glycolic acid) (PLGA) microparticles containing the drug SKL-2020 have been investigated. On increasing polyvinyl alcohol (PVA) concentration (from 0.2% to 5%), the size of microparticles decreased (from $48.02{\mu}m$ to $10.63{\mu}m$) and more uniform size distribution was noticeable due to the powerful emulsifying ability of PVA. A higher drug loading (from 5% to 20%) caused a larger concentration gradient between 2 phases at the polymer precipitation step; this resulted in decreased encapsulation efficiency (from 34.19% to 25.67%) and a greater initial burst (from 61.71% to 70.05%). SKL-2020-loaded PLGA microparticles prepared with different fabrication conditions exhibited unique release patterns of SKL-2020. High PVA concentration and high drug loading led to an initial burst effect by rapid drug diffusion through the polymer matrix. Since PLGA microparticles enabled the slow release of SKL-2020 over 1 week in vitro and in vivo, more convenient and comfortable treatment could be facilitated with less frequent administration. It is feasible to design a release profile by mixing microparticles that were prepared with different fabrication conditions. By this method, the initial burst could be repressed properly and drug release rate could decrease.

Functionalized Raspberry-Like Microparticles obtained by Assembly of Nanoparticles during Electrospraying

  • Cho, Eun Chul;Hwang, Yoon Kyun;Jeong, Unyong
    • Bulletin of the Korean Chemical Society
    • /
    • v.35 no.6
    • /
    • pp.1784-1788
    • /
    • 2014
  • The present study suggests a novel method to produce raspberry-like microparticles containing diverse functional materials inside. The raspberry-like microparticles were produced from a random assembly of uniformly-sized poly(methyl methacrylate) (PMMA) nanoparticles via electrospraying. The solution containing the PMMA nanoparticles were supplied through the inner nozzle and compressed air was emitted through the outer nozzle. The air supply helped fast evaporation of acetone, so it enabled copious amount of microparticles as dry powder. The microparticles were highly porous both on the surface and interiors, hence various materials with a function of UV-blocking ($TiO_2$ nanoparticles and methoxyphenyl triazine) or anti-aging (ethyl(4-(2,3-dihydro-1H-indene-5-carboxyamido) benzoate)) were loaded in large amount (17 wt % versus PMMA). The surface and interior structures of the microparticles were dependent on the characteristics of functional materials. The results clearly suggest that the process to prepare the raspberry-like microparticles can be an excellent approach to generate functional microstructures.

New polyester composites synthesized with additions of different sized ZnO to study their shielding efficiency

  • M. Elsafi;M.I. Sayyed;Aljawhara H. Almuqrin
    • Nuclear Engineering and Technology
    • /
    • v.56 no.7
    • /
    • pp.2821-2827
    • /
    • 2024
  • This investigation developed a novel polyester composite based on the addition of zinc oxide (ZnO) of different sizes. We prepared nine samples Containing different percentages and sizes of ZnO as well as the control sample (Pol-ZnO0). The attenuation factors of Pol-micro ZnO were estimated using Phy-x software, while the HPGe detector and various gamma sources were used to experimentally measure the all-prepared composites. In terms of the two methods for micro composites, good agreement was observed. The linear attenuation coefficient (LAC) of Pol-ZnO20, Pol-ZnO40, and Pol-ZnO60, two more samples one with ZnO nanoparticles instead of microparticles, and the other with half microparticles and half nanoparticles (referenced as 0.5 M + 0.5 N) were determined. For all the Polyester composites and energies, the mixture of microparticles and nanoparticles had greater LAC values than each of the particles on their own. For example, the LAC values for the Pol-ZnO20 polymer at 1.330 MeV are 0.0836, 0.0888, and 0.0903 cm-1 for the microparticles, nanoparticles, and mixture, respectively. The values of the prepared polymer samples' radiation protection efficiency (RPE) against energy with a thickness of 2 cm was determined experimentally. The Pol-ZnO60 0.5 M + 0.5 N sample has the highest RPE out of all the samples, followed by its nanoparticle counterpart, and then its microparticle counterpart. On the other hand, the Pol-ZnO0 sample, the polymer with no ZnO content, at all energies has the lowest RPE, followed by the three Pol-ZnO20 samples.

The New Strategy of Formulation of Human Growth Hormone Aggregate within PLGA Microspheres for Sustained Release

  • Kim, Hong-Gi;Park, Tae-Gwan
    • 한국생물공학회:학술대회논문집
    • /
    • 2000.04a
    • /
    • pp.541-545
    • /
    • 2000
  • For the sustained release formulation of recombinant human growth hormone (rhGH), dissociable rhGH aggregates were microencapsulated within poly(D,L-lactic-co-glycolic acid) [PLGA] microparticles. rhGH aggregates with 2 - 3 m Particle diameter were first produced by adding a small volume of aqueous rhGH solution into a partially water miscible organic solvent phase(ethyl acetate) containing PLGA. These rhGH aggregates were then microencapsulated within PLGA polymer phase by extracting ethyl acetate into an aqueous phase pre-saturated with ethyl acetate. The resultant microparticles were 2 - 3 m in diameter similar to the size of rhGH aggregates, suggesting that PLGA polymer was coated around the protein aggregates. Release profiles of rhGH from these microparticles were greatly affected by changing the volume of the incubation medium. The release rhGH species consisted of mostly monomeric form with having a correct conformation. This study reveals that sustained rhGH release could be achieved by microencapsulating reversibly dissociable protein aggregates within biodegradable polymers.

  • PDF

Preparation of BCNU-loaded PLGA Wafers and In Vitro Release Behavior (BCNU 함유 PLGA 웨이퍼의 제조와 생체외 방출거동)

  • 성하수;문대식;강길선;이정식;이해방
    • Polymer(Korea)
    • /
    • v.26 no.1
    • /
    • pp.128-138
    • /
    • 2002
  • 1,3-Bis(2-chloroethyl)-1-nitrosourea (BCNU, Carmustine)-loaded poly(D, L-lactide-co-glycolide) (PLGA, lactide/glycolide mole ratio 75 : 25) microparticles were prepared and fabricated into wafers in an attempt to study the possibility for the treatment of malignant glioma by direct inserting the wafers to the tumor or the cavity remained after surgical resection of the tumor. SEM observation of the microparticles prepared by spray drying method revealed that the microparticles were spherical, i. e. microspheres. Significant reduction of the crystallinity of BCNU encapsulated in PLGA was confirmed by X-ray diffraction and differential scanning calorimetry analyses of the BCNU-loaded PLGA microparticles. Release pattern of BCNU was dependent on several preparation parameters, such as the molecular weight and concentration of PLGA, and initial BCNU loading amount, etc. In vitro release of BCNU was prolonged over 8 weeks with close to zero-order release pattern after initial burst effect. Observations of morphological change of wafers and pH change of release media during release test period confirmed that hydration and degradation of PLGA would be facilitated with an increase of BCNU-loading amount.